JCXH-212
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JCXH-212, covering 2024-05-14 to 2024-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors [EARLY_Phase 1]